> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Drug Development Glossary
- URL: https://www.fdaweb.com/comments-sought-on-drug-development-glossary/
- Published: 2019-07-25T12:00:00.000Z
- Updated: 2026-09-15T01:40:08.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144619

*Federal Register* notice: FDA is seeking comments on the agency’s publication of a glossary of terms which is part of the BEST (Biomarkers, Endpoints, and other Tools) Resource Taxonomy. FDA has developed a Web page that describes the resource, which links to the official National Library of Medicine Web page for the BEST glossary of terms. Comments received will help the agency to enhance its utility and may assist it in developing future versions of the resource and identifying best methods for conveying information about biomarkers, endpoints, and other drug development tools to the general public. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-07-25/pdf/2019-15827.pdf?ref=fdaweb.com).